Loading
IARC estimates 1,921 new cancer cases and 1,387 cancer deaths in The Gambia in 2024; the commonest new cancers are liver and intrahepatic bile ducts, cervix uteri and breast. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Liver and intrahepatic bile ducts | 503 | 31.0 | Hepatocellular carcinoma |
| Cervix uteri | 447 | 48.8 | Cervical cancer |
| Breast | 161 | 17.6 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 100 | 17.5 | Prostate cancer |
| Trachea, bronchus and lung | 82 | 6.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 73 | 5.0 | Colorectal cancer |
| Stomach | 55 | 3.9 | Gastric & gastro-oesophageal junction cancer |
| Ovary | 44 | 4.7 | Ovarian cancer |
| Pancreas | 42 | 3.1 | Pancreatic ductal adenocarcinoma |
| Brain, central nervous system | 39 | 1.9 | Glioma & glioblastoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Liver and intrahepatic bile ducts | 450 | 28.4 | Hepatocellular carcinoma |
| Cervix uteri | 264 | 29.6 | Cervical cancer |
| Breast | 77 | 8.8 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 68 | 5.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Prostate | 60 | 10.6 | Prostate cancer |
| Stomach | 49 | 3.6 | Gastric & gastro-oesophageal junction cancer |
| Colorectum | 41 | 2.9 | Colorectal cancer |
| Pancreas | 41 | 3.1 | Pancreatic ductal adenocarcinoma |
| Brain, central nervous system | 37 | 1.9 | Glioma & glioblastoma |
| Ovary | 29 | 3.4 | Ovarian cancer |
No trial record in OnCo lists a site in The Gambia. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in The Gambia.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. The Gambia is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
The Gambia is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.